Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Radiation vs Chemoradiation in Intermediate Risk Cervical Cancer
NCT01101451Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Apr 2010
- Primary completion
- Jan 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in Cervical Cancer (CC), sponsored by GOG Foundation. Started Apr 2010; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01101451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101451.